Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00609609 · ClinicalTrials.gov registry record · Phase 2
Photopheresis for the Treatment of Acute Graft Versus Host Disease
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 81
- Enrollment target
NCT00609609: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT00609609 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 81 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00609609, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 81 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to find out whether adding extracorporeal photopheresis (ECP) to standard therapy for acute GVHD with corticosteroids improves response to treatment, length of treatment, and survival.
Interventions
- DRUG Methylprednisolone
- PROCEDURE Photopheresis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2008-01 |
| Est. Completion | 2016-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00609609
The ClinicalTrials.gov registry entry for NCT00609609 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methylprednisolone is the first listed.
NCT00609609 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00609609 about?
NCT00609609 is a clinical study titled "Photopheresis for the Treatment of Acute Graft Versus Host Disease". The goal of this clinical research study is to find out whether adding extracorporeal photopheresis (ECP) to standard therapy for acute GVHD with corticosteroids improves response to treatment, length of treatment, and survival.
What is the current status of trial NCT00609609?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 81 participants. The study started on 2008-01. Estimated completion is 2016-01.
What interventions are being tested in trial NCT00609609?
The interventions under investigation include: Methylprednisolone (DRUG), Photopheresis (PROCEDURE).
Who is sponsoring clinical trial NCT00609609?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.